drugset / Trial / NCT01673074
HPPH and PDT for Pleural Malignancy
Treatment
Summary
The primary objective of the study is to determine the maximally tolerated photodynamic therapy (PDT) dose and drug-light interval of PDT using light and HPPH in patients with pleural malignancy who have undergone a maximal resection.
Timeline
- Start
- 2007-11
- Primary completion
- 2013-12
- Completion
- 2014-10-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 2-(1-HEXYLOXYETHYL)-2-DEVINYL PYROPHEOPHORBIDE-A | Unknown | — | Intravenous |